HIV检测与咨询6个月后强化咨询环节的效果:一项随机对照试验(RESPECT-2)
Efficacy of a booster counseling session 6 months after HIV testing and counseling: a randomized, controlled trial (RESPECT-2).
作者信息
Metcalf Carol A, Malotte C Kevin, Douglas John M, Paul Sindy M, Dillon Beth A, Cross Helene, Brookes Lesley C, Deaugustine Nettie, Lindsey Catherine A, Byers Robert H, Peterman Thomas A
机构信息
Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.
出版信息
Sex Transm Dis. 2005 Feb;32(2):123-9. doi: 10.1097/01.olq.0000151420.92624.c0.
BACKGROUND
HIV counseling prevents sexually transmitted diseases (STDs), with most of the benefit accumulating in the first 6 months.
STUDY
The authors conducted a multicenter, randomized, controlled trial of a 20-minute additional (booster) counseling session 6 months after HIV counseling compared with no additional counseling for prevention of STDs (gonorrhea, chlamydia, trichomoniasis). Participants were 15- to 39-year-old STD clinic patients in Denver, Long Beach, and Newark.
RESULTS
Booster counseling was completed by 1120 (67.8%) of 1653 assigned to receive it. An incident STD during the 6 to 12 months after initial counseling (and within the 6 months after scheduled booster counseling) was detected in 141 of 1653 (8.5%) participants in the booster counseling group and 144 of 1644 (8.8%) in the no-booster group (relative risk, 0.97; 95% confidence interval, 0.78-1.22). Three months after booster counseling, sexual risk behaviors were reported less frequently by the booster group than the no-booster group.
CONCLUSIONS
Booster counseling 6 months after HIV testing and counseling reduced reported sexual risk behavior but did not prevent STDs.
背景
HIV咨询可预防性传播疾病(STD),大部分益处集中在前6个月。
研究
作者进行了一项多中心、随机、对照试验,对比了HIV咨询6个月后额外增加20分钟(强化)咨询与不进行额外咨询对预防性传播疾病(淋病、衣原体感染、滴虫病)的效果。参与者为丹佛、长滩和纽瓦克15至39岁的性病门诊患者。
结果
分配接受强化咨询的1653人中,1120人(67.8%)完成了强化咨询。强化咨询组1653名参与者中有141人(8.5%)在初次咨询后6至12个月(以及预定强化咨询后6个月内)出现了新发STD,无强化咨询组1644人中有144人(8.8%)出现新发STD(相对风险,0.97;95%置信区间,0.78 - 1.22)。强化咨询3个月后,强化咨询组报告的性风险行为比无强化咨询组少。
结论
HIV检测和咨询6个月后进行强化咨询可减少报告的性风险行为,但不能预防性传播疾病。